CELLS FOR PRODUCING RECOMBINANT IDURONATE-2-SULFATASE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20180010108A1
SERIAL NO

15650536

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides, among other things, methods and compositions for production of recombinant I2S protein with improved potency and activity using cells co-express I2S and FGE protein. In some embodiments, cells according to the present invention are engineered to simultaneously over-express recombinant I2S and FGE proteins. Cells according to the invention are adaptable to various cell culture conditions. In some embodiments, cells of the present invention adaptable to a large-scale suspension serum-free culture.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHIRE HUMAN GENETIC THERAPIES INC300 SHIRE WAY LEXINGTON MA 02421

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boldog, Ferenc Lexington, US 21 158
Heartlein, Michael Lexington, US 223 2893

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation